Pathological complete remission after conversion therapy with XELOX regimen for stage IV gastric cancer: a report of 2 cases and literature review
10.3760/cma.j.cn341190-20221017-00804
- VernacularTitle:Ⅳ期胃癌XELOX方案转化治疗后病理完全退变2例并文献复习
- Author:
Yinghua WANG
1
;
Xingwei ZHONG
;
Shuangwei QIN
;
Zhen WANG
Author Information
1. 云南省滇南中心医院（红河哈尼族彝族自治州第一人民医院）普通外科，个旧 651000
- Keywords:
Stomach neoplasms;
Antineoplastic combined chemotherapy protocols;
Antineoplastic agents;
Oxaliplatin;
Capecitabine;
Transformational therapy;
Case reports
- From:
Chinese Journal of Primary Medicine and Pharmacy
2023;30(9):1291-1294
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinical efficacy of conversion therapy with XELOX regimen in the treatment of stage IV advanced gastric cancer.Methods:The diagnosis and treatment process of two patients with stage IV gastric cancer who were diagnosed and treated in Southern Central Hospital of Yunnan Province (The First People's Hospital of Honghe State) in September 2018 and July 2019 were retrospectively analyzed. The performance of conversion therapy with XELOX regimen in the treatment of stage IV gastric cancer was analyzed based on relevant literature.Results:Pathological complete remission of stage IV gastric cancer was achieved in both patients after conversion therapy with XELOX regimen.Conclusion:Conversion therapy with XELOX regimen is effective on stage IV gastric cancer and is worthy of clinical promotion.
